Aldo Jongejan

5.7k citations

129 papers · 3.4k indexed · h-index 31

Impact in

Aging top 2%
Immunology top 2%
- Mast cells and histamine
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses

Papers in

Aging 5
Immunology 32
- Mast cells and histamine 11
- Immune Cell Function and Interaction 8

Co-authors: Rob Leurs Iwan J. P. de Esch Perry D. Moerland Remko A. Bakker Robin L. Thurmond Martine J. Smit Leonardo Pardo Antoine H. C. van Kampen
Journals: Journal of Medicinal Chemistry (6 papers)PLoS ONE (6 papers)Scientific Reports (4 papers)Nature Communications (4 papers)Acta Neuropathologica Communications (3 papers)
Partner nations: Netherlands United States Canada

In The Last Decade

Aldo Jongejan

125 papers receiving 3.4k citations

Peers

Countries citing papers authored by Aldo Jongejan

Since Specialization

Citations

This map shows the geographic impact of Aldo Jongejan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldo Jongejan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldo Jongejan more than expected).

Fields of papers citing papers by Aldo Jongejan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldo Jongejan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldo Jongejan. The network helps show where Aldo Jongejan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Aldo Jongejan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aldo Jongejan Line = papers co-authored together Aldo Jongejan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	UBE3A promotes foam cell formation and counters remyelination by targeting ABCA1 for proteasomal degradation Nature Communications ·Melanie Loix, Sam Vanherle, Pauschardt, Sanne G. S. Verberk, Qichao Wang, Franco Verdessi, 早山登世美, Sungwhee Shin, Reddymalla Sai Kumar Reddy, Aldo Jongejan, Ben Distel, Ype Elgersma, Mansour Haidar, Noam Zelcer, Jerome J. A. Hendriks, Jeroen F. J. Bogie	2025	1
2	Circadian clock disruption promotes retinal photoreceptor degeneration The FASEB Journal ·Renato Porto Barcelos, Cristina Sandu, Serhii Grevtsov, Jacoline B. ten Brink, Roberta Ferlini, Aldo Jongejan, Perry D. Moerland, Arthur A. Bergen, Marie‐Paule Felder‐Schmittbuhl	2025	3
3	ENCORE: a practical implementation to improve reproducibility and transparency of computational research Nature Communications ·Antoine H. C. van Kampen, Yoshie Inoue, Aldo Jongejan, Barbera D. C. van Schaik, Luka Srića, J Hals, Mia L. Pras‐Raves, Eric Wever, Mahboob Rabbani, Zahra Faghih, Perry D. Moerland	2024	3
4	Lipidomic biomarkers in plasma correlate with disease severity in adrenoleukodystrophy SHILAP Revista de lepidopterología ·Mitch Dowsett FMedSci, 黄树武, Caroline G. Bergner, Inge M. E. Dijkstra, Irene C. Huffnagel, Reinhard Wagenhofer, Eric Wever, Gajja S. Salomons, Frédéric M. Vaz, Aldo Jongejan, M. Vanaee, Víctor Antonio Ampuero Mendoza, Troy C. Lund, Wolfgang Köhler, Marc Engelen, Stephan Kemp	2024	9
5	Analysis of genes differentially expressed in the cortex of mice with the Tbl1xr1 variant Gene ·Sebastian Deslot, Emily J. Prokesch, Aldo Jongejan, Ling Huang, Eveline Bruinstroop, A S Paul van Trotsenburg, Eric Fliers, Raoul C. M. Hennekam, Anita Boelen	2024	0
6	Distinct transcriptional changes distinguish efficient and poor remyelination in multiple sclerosis Brain ·D Angela, Niamh B. McNamara, Hendrik J. Engelenburg, Aldo Jongejan, N.V. Lysak, 公美子瀬野, 元太輝幸, Hong Huang, Fred de Winter, Perry D. Moerland, Joost Smolders, Joost Verhaagen, Jörg Hamann, Inge Huitinga	2024	5
7	Chronic lymphocytic leukemia presence impairs antigen-specific CD8+ T-cell responses through epigenetic reprogramming towards short-lived effectors Leukemia ·Anne W. J. Martens, Inga Kavazović, Eldar Andreevich Belyaev, 典和廣瀬, Ramon Arens, Aldo Jongejan, Perry D. Moerland, Eric Eldering, Gerritje J. W. van der Windt, Felix M. Wensveen, A. Kumar, Arnon P. Kater	2023	14
8	Hepatic SREBP signaling requires SPRING to govern systemic lipid metabolism in mice and humans Nature Communications ·Analía Jacob, Ιωάννης Κλαψόπουλος, Roelof Ottenhoff, Олена Пелешенко, Monika Svecla, Thomas van Pelt, Vinay Sachdev, عاليه محمد الخياط, Johannes H.M. Levels, Aldo Jongejan, Jan Freark de Boer, Folkert Kuipers, Antoine Rimbert, Giuseppe Danilo Norata, Anke Loregger, Noam Zelcer	2023	23
9	An animal model for Pierpont syndrome: a mouse bearing the Tbl1xr1 Y446C/Y446C mutation Human Molecular Genetics ·Sebastian Deslot, Emily J. Prokesch, Michelle Stewart, Gemma Codner, Steffen Mayerl, Heike Heuer, Lily Ng, Douglas Forrest, A S Paul van Trotsenburg, Aldo Jongejan, Eric Fliers, Raoul C. M. Hennekam, Anita Boelen	2022	8
10	Sterol-regulated transmembrane protein TMEM86a couples LXR signaling to regulation of lysoplasmalogens in macrophages Journal of Lipid Research ·Reddymalla Sai Kumar Reddy, Marlene van den Berg, Murat Orunkhanov, Z. Vecsey, Ιωάννης Κλαψόπουλος, Roelof Ottenhoff, Melanie Loix, Marten A. Hoeksema, Koen H.M. Prange, Gerard Pasterkamp, Jerome J. A. Hendriks, Jeroen F. J. Bogie, Jan B. van Klinken, Frédéric M. Vaz, Aldo Jongejan, Menno P.J. de Winther, Noam Zelcer	2022	7
11	Inhibition of the neuromuscular acetylcholine receptor with atracurium activates FOXO/DAF‐16‐induced longevity Aging Cell ·Rebecca L. McIntyre, Simone Denis, Rashmi Kamble, Marte Molenaars, Michael Petr, Bauke V. Schomakers, Mizanur Rahman, Siddhartha Datta Gupta, Márton L. Tóth, Siva A. Vanapalli, Aldo Jongejan, Morten Scheibye‐Knudsen, Riekelt H. Houtkooper, Georges E. Janssens	2021	16
12	TBX2, a Novel Regulator of Labour Medicina ·Febilla Fernando, Geertruda J. M. Veenboer, Martijn A. Oudijk, M. A. M. Kampman, Karst Y. Heida, I. Hundere, Joris van der Post, Aldo Jongejan, Gijs Afink, Carrie Ris‐Stalpers	2021	2
13	Framing the potential of public frameshift peptides as immunotherapy targets in colon cancer PLoS ONE ·Shakiba Ghadir Jamal Abad, A. Kumar, Aldo Jongejan, E. Redeker, Cornelis J.A. Punt, Adriaan D. Bins	2021	7
14	Catecholamines are key modulators of ventricular repolarization patterns in the ball python (Python regius) The Journal of General Physiology ·Bastiaan J. Boukens, William Joyce, Florian Bénitière, Ingeborg B. Hooijkaas, Aldo Jongejan, Tobias Wang, Bjarke Jensen	2021	1
15	Comparing genome-scale DNA methylation and CNV marks between adult human cultured ITGA6+ testicular cells and seminomas to assess in vitro genomic stability PLoS ONE ·César Enrique Trejo Segovia, Lambert C. J. Dorssers, Peter Henneman, Martin A. Rijlaarsdam, Andrea Venema, Aldo Jongejan, Marcel M. A. M. Mannens, Leendert H. J. Looijenga, Sjoerd Repping, Ans M. M. van Pelt	2020	11
16	In Rheumatoid Arthritis, Synovitis at Different Inflammatory Sites Is Dominated by Shared but Patient-Specific T Cell Clones The Journal of Immunology ·Anne Musters, Paul L. Klarenbeek, Marieke E. Doorenspleet, 伴幸高橋, R. E. Esveldt, Barbera D. C. van Schaik, Aldo Jongejan, Sander W. Tas, Antoine H. C. van Kampen, Frank Baas, Niek de Vries	2018	27
17	In silico analysis of the Mus musculus uterine gene expression landscape during pregnancy identifies putative upstream regulators for labour PLoS ONE ·Febilla Fernando, Thu Hái Tại, Aldo Jongejan, Joris van der Post, Gijs Afink, Carrie Ris‐Stalpers	2018	1
18	Trivial role for NSMCE2 during in vitro proliferation and differentiation of male germline stem cells Reproduction ·Yi Zheng, Aldo Jongejan, C.L. Mulder, Sebastiaan Mastenbroek, Sjoerd Repping, Yinghua Wang, Jinsong Li, Geert Hamer	2017	16
19	Unraveling transcriptome dynamics in human spermatogenesis Development ·Sabrina Z. Jan, Tinke L. Vormer, Aldo Jongejan, Carlos Volponi, Sherman J. Silber, Dirk G. de Rooij, Geert Hamer, Sjoerd Repping, Ans M. M. van Pelt	2017	128
20	Mitochondrial NADP(H) deficiency due to a mutation in NADK2 causes dienoyl-CoA reductase deficiency with hyperlysinemia Human Molecular Genetics ·Sander M. Houten, Simone Denis, Heleen te Brinke, Aldo Jongejan, Antoine H. C. van Kampen, Eddie Bradley, Frank Baas, Raoul C. M. Hennekam, David S. Millington, Sarah P. Young, Dianne M. Frazier, Müge Güçsavaş‐Çalıkoğlu, Ronald J. A. Wanders	2014	54

About Aldo Jongejan

Aldo Jongejan is a scholar working on Aging, Immunology, Cancer Research, Molecular Biology and Endocrine and Autonomic Systems, having authored 129 papers that have together received 3.4k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (13 papers), Mast cells and histamine (11 papers), RNA Research and Splicing (9 papers), Immune Cell Function and Interaction (8 papers), MicroRNA in disease regulation (8 papers), CAR-T cell therapy research (7 papers), Chronic Lymphocytic Leukemia Research (6 papers) and Neuropeptides and Animal Physiology (6 papers). The work is most often cited by research in Aging (94 citations), Immunology (974 citations), Molecular Biology (1.7k citations), Endocrine and Autonomic Systems (144 citations) and Cellular and Molecular Neuroscience (387 citations). Aldo Jongejan has collaborated with scholars based in Netherlands, United States and Canada. Frequent co-authors include Rob Leurs, Iwan J. P. de Esch, Perry D. Moerland, Remko A. Bakker, Robin L. Thurmond, Martine J. Smit, Leonardo Pardo, Antoine H. C. van Kampen, Henk Timmerman and Eric Haaksma. Their work appears in journals such as Journal of Medicinal Chemistry, PLoS ONE, Scientific Reports, Nature Communications and Acta Neuropathologica Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact